Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breathing trouble after jaw surgery? this trial tests a simple spray

NCT ID NCT05839756

First seen Feb 20, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study tests whether a nebulized steroid (budesonide) can prevent stridor—a noisy, difficult breathing caused by airway swelling—after jaw surgery. 62 adults having elective jaw surgery will receive either budesonide or a placebo before surgery. The goal is to see if the steroid reduces airway narrowing and breathing complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STRIDOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maha Ahmed AboZeid

    RECRUITING

    Al Mansurah, Mansoura, 35511, Egypt

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

budesonide

What this could lead to

If it works, this could point toward a simple way to prevent breathing problems after jaw surgery.

What could go wrong

This is a small, early-stage trial with only 62 people, so results may not apply to everyone. The treatment may not reduce stridor risk.

Conditions

The condition(s) this trial relates to.

Laryngeal Edema Respiratory Sounds

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.